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Introduction
The tumor-node-metastasis (TNM) staging system of 
the American Joint Cancer Committee (AJCC)/Union 
for International Cancer Control (UICC) is a tool 
originally conceived for description of disease extent, 
aimed at providing prognostic information and making 
useful “post hoc” comparisons possible between different 
centers/series and/or therapeutic strategies. Nevertheless, 
in everyday clinical practice, it is frequently (and 
inappropriately) employed “upfront” in choosing primary 
and/or complementary treatment(s) for a given patient. 
To correctly assign outcomes categories and possibly (de-)
escalate treatment accordingly, a staging system should 
identify distinct prognostic stratifications that must be 
internally homogeneous, while at the same time differing 
from one another. Moreover, when aiming towards more 
finely-tuned staging accuracy, TNM should remain 
relatively simple, user friendly, and reproducible.
Oral cavity squamous cell cancer (SCC) is the most 
common head and neck neoplasm, and in some countries 
still represents one of the leading causes of cancer-specific 
mortality, with the tongue the most frequently encountered 
localization. Despite numerous improvements in treatment, 
the prognostic landscape of tongue SCC remains poor, with 
nodal metastasis occurring frequently, and representing the 
most important prognosticator in terms of loco-regional 
control and survival (1-3). Thus, a reliable criterion in 
distinguishing lesions with a low or high risk of nodal 
metastasis could greatly help in shaping the prognostic 
outcomes of patients and provide information of paramount 
importance when choosing the type and extent of primary 
or complementary treatment(s).
The 7th Edition of the AJCC/UICC TNM staging 
system, based on a crude two-dimensional definition of the 
T category, was lacking adequate prognostic performance 
when applied to tongue SCC, since it failed to distinguish 
“early” lesions that can potentially develop nodal metastases, 
from true early tumors without such regional spread (4,5). 
The 8th Edition was therefore recently updated, and staging 
for oral cavity SCC has changed significantly. In fact, in 
response to growing evidence, a well-known pathological 
feature, namely depth of invasion (DOI), was introduced as 
a fundamental staging criterion to define T1, T2, and T3 
categories as it shows significant correlation with disease 
specific survival (DSS) (6,7). Moreover, DOI correlates 
well with the risk of nodal metastasis and loco-regional 
recurrence, especially in tongue SCC (1,2,6,8,9). Extranodal 
extension was also added to the N classification of every 
non-viral related tumor of the upper aero-digestive tract, 
given its profound negative effect on prognosis in terms of 
not only regional, but also local and distant relapses (7). 
The first validation studies of the last edition of the 
AJCC/UICC TNM staging system demonstrated good 
prognostic distinction between early- and advanced-stage 
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tongue SCC compared to the 7th Edition (7). However, the 
actual efficacy of such a new tool and its impact on stage 
distribution of tongue cancer remains a matter of debate, 
and should be addressed by a larger number of prospective 
and retrospective studies from different centers.
Validation?
The prognostic performance of the 8th Edition of the 
TNM applied to tongue SCC has been already tested 
by many authors. In a recent validation study, Kano and 
coworkers (10) observed that the T3 category was internally 
homogeneous, since DSS curves of patients formerly 
belonging to the T2, T3, and T4a categories according 
to the 7th Edition, and then reclassified on the base of the 
DOI parameter, were almost overlapping when grouped 
together in the 8th Edition T3 category. Moreover, in the 
latter TNM version, the T2 category showed significantly 
improved DSS, in line with what is routinely observed in 
clinical practice. Indeed, tongue tumors with a superficial 
diameter between 2 and 4 cm (former T2) frequently have 
a DOI >10 mm (and are therefore now reclassified as T3). 
Removing from the T2 group this kind of tumors, now 
leaves in such category those with a better prognosis (DOI 
in between 5 and 10 mm), consistent with the concept of 
T2 itself. On the other hand, no significant change was 
observed in DSS for T1 and T3 lesions, indicating that the 
7th Edition had already adequately identified, on the basis 
of two-dimensional criterion (<2 cm for T1 and >4 for T3), 
most tumors with a DOI <5 or >10 mm, respectively. 
Conversely, Kano and colleagues found that DSS for 
tongue SCC was not significantly different between T1 
and T2 diseases (10). Similarly, other authors observed an 
improvement in discriminating between early-stage (T1/
T2N0) and advanced-stage diseases considering both 
overall survival (OS) and DSS, while stratification proved 
unsatisfactory when trying to differentiate T1 from T2N0 
disease (4,10-12). The stage migration effect previously 
described can partially justify the results herein observed. 
Moreover, this phenomenon was more significant when 
restaging was performed according to pathological DOI 
(measured from the level of the basement membrane 
adjacent to normal mucosa to the deepest point of tumor 
invasion) rather than on the basis of clinical DOI (12). 
The present data reinforce the concept that DOI 
correlates well with the risk of nodal metastasis in oral cavity 
SCC (2,8,9,13), with a risk of loco-regional recurrence that 
increases for any DOI, in a clinically negative neck, with 
a sharp cumulative risk from 2 to 6 mm (2,8). As noted 
many years ago, nodal metastasis has a profound and dismal 
impact on prognosis, with a 50% reduction of 5-year DSS 
in patients showing positive neck nodes (1). DSS for tongue 
SCC decreases, passing from T2 to T3N0 disease, as the 
prevalence of loco-regional recurrence greatly increases for 
an infiltration deeper than 10 mm (10,14-16). According 
to many studies, in fact, 10 mm is the threshold of DOI 
predicting a decline in both DSS and disease-free survival 
(DFS) for tongue cancer (10,13-15). This is also favorably 
explained on the basis of anatomical considerations, taking 
into account that at around 10 mm from the mucosal surface 
the complex array of extrinsic tongue muscles becomes even 
more represented than in the superficial layers of the organ, 
and may be thus responsible for unpredictable distant tumor 
progression along the muscular fibers and neurovascular 
bundles contained in the paramedian and lateral lingual 
connective septa (5).
By contrast, retrospective validation studies showed a 
similar DSS for T1 and T2N0 disease as identified by the 
last edition of the TNM staging system (4,10-12). This was 
another effect of the staging migration described above: 
since survival of T2N0 tongue SCC improved as more 
invasive cancers were clustered in Stage III disease, the 
existent gap between T1 and T2N0 scenarios was reduced 
in a parallel way (4,10-12,17). At the same time, small cancers 
(<2 cm), infiltrating in depth more than 5 mm, migrated 
from T1 to T2. Interestingly, according to Kano et al. (10), 
no significant difference was found between tongue SCC 
prognostic groups separated by a DOI of 5 mm, while such a 
distinction proved real when the groups were separated by a 
DOI of 10 mm, thus reinforcing the anatomical concepts of 
tongue compartmentalization (5,10,18).
Prognosis of early-stage cancers of the tongue and oral 
cavity is quite good, with a mean OS and DSS of 75% and 
89%, respectively. The most important predictor of survival 
for early-stage tongue SCC with a clinically negative neck is 
the presence of occult nodal metastasis, with a prevalence in 
the literature that ranges from 8.2% to 46.3% (1-3). In fact, 
patients with occult nodal metastasis have a 5-fold increased 
risk of dying for disease (1). Therefore, correct assessment 
of the risk of nodal metastasis is crucial in deciding 
whether the patient could benefit from upfront or staged 
elective neck dissection and to correctly define the ensuing 
prognosis (17). According to every current risk-decision 
tree analysis, prophylactic neck dissection in cN0 patients is 
considered cost-effective when the risk of nodal metastasis 
exceeds 20% (17). DOI was found to be an excellent 
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predictor of occult nodal metastasis from oral cavity SCC 
with a clinically negative neck (9,13) and therefore it is 
potentially an extremely powerful instrument to predict 
the incidence of nodal spread and, hence, prognosis. 
Unfortunately, a robust enough threshold to predict which 
patient may harbor occult nodal metastasis, and display the 
related prognostic decrease, is still unknown. According 
to the literature, the optimal DOI cut-off used to establish 
the need for elective neck dissection can be extremely 
heterogeneous, ranging from 3 to 10 mm among different 
series (2,9,13). On top of this, the frequency of occult nodal 
metastasis in early-stage oral cavity SCC greatly varies 
depending on the primary subsite. For example, nodal 
metastasis occurs in 11.2% of tongue SCC with a thickness 
between 2 and 4 mm, while cancer of the floor of the 
mouth with an identical DOI has a frequency of metastasis 
that is significantly higher by 41.7% (19). Therefore, it is 
unlikely that a DOI cut-off of 5 mm can predict the risk 
of occult nodal metastasis for SCC of the entire oral cavity 
or for any of its subsites. The difference between the DOI 
threshold chosen for upstaging oral cavity SCC from T1 
to T2 (5 mm), and to decide for elective neck dissection 
(which is usually set around 4 mm), brings a relevant risk of 
occult nodal metastasis for both T1 and T2 disease (9,13). 
Therefore, T1 disease frequently behaves similarly to T2, 
showing nodal metastasis and worse prognosis. Lowering 
the DOI cut-off used to upstage T1 to T2 probably would 
not significantly improve the distinction between Stage I 
and II diseases. In a recent work, in fact, Almangush et al. 
reclassified 311 early-stage tongue SCC, suggesting a 2 mm 
DOI cut-off to upstage to T2 and a 4 mm threshold for 
upstaging to T3. According to their proposal, T3 disease 
had an even worse DSS, but the difference between T1 and 
T2N0 was still not significant (11).
Open questions
As the two-dimensional criterion previously applied in the 
7th Edition, the DOI parameter introduced in the last one 
also falls short if one uses it as the only histopathologic 
characteristic predicting node metastasis or DSS. From this 
observation, it directly derives that other factors should be 
taken into account when studying prognosis of oral cavity 
and, particularly, tongue SCC, as they all might play a 
role, heavily influencing the risk of nodal metastasis and 
survival. Nomograms and prediction models, developed 
using large (but retrospective) cohorts, showed excellent 
accuracy for predicting 5-year OS or determining the 
probability of nodal metastasis (8,20,21). These models use 
many other clinically-relevant variables such as age, pattern 
of invasion, perineural and lympho-vascular involvement, 
or primary site of cancer occurrence to correlate with OS 
or nodal metastasis (8,20,21). It might be that these factors 
could obfuscate the role played by DOI and tumor size 
in separating T1 from T2 diseases. On the other hand, 
prediction scores and nomograms often show a higher 
degree of inherent complexity, demanding elaborated 
histopathologic evaluations that severely limit their overall 
applicability and reproducibility, especially from the cT and 
cN point of view.
At the same time, clinical DOI assessment should be 
refined since it is of crucial importance in the treatment-
planning phase. So far it is usually ascertained through 
clinical examination and imaging, mostly magnetic 
resonance (MR) (10): measurements of the size and DOI 
of a given tumor allow to precisely refine clinical staging 
and thus help in choosing the extent of resection, need 
for compartmental surgery, possible reconstruction, and/
or neck dissection (18,22). Previous studies, although 
retrospective, supported the employment of MR in the 
clinical assessment of DOI (23,24) underlying a good 
correlation between tumor thickness by MR and histologic 
DOI, even though imaging usually overestimates the latter, 
probably due to the coexistence of at least two phenomena: 
peritumoral edema on one hand, and shrinkage of the 
specimen after surgical resection and fixation on the 
other (23,24). Notably, imaging accuracy may be reduced 
when evaluating T1 lesions, as neither clinical nor MR 
measurements correlated well with a pathological DOI less 
than 5 mm (24). 
Another limit of the current imaging modalities is 
represented by the impossibility to preoperatively detect 
nodal micro-metastases. Therefore, once surgery of the 
primary site has been completed and DOI pathologically 
demonstrated to be above a given alert threshold, neck 
dissection should be prophylactically performed with staging 
purposes within 40 days from resection of the oral cancer. 
However, management of the cN0 neck in tongue SCC is 
still controversial: occult nodal metastasis in such a clinical 
scenario may range between 20% and 44% and, therefore, 
neck dissection would cause unnecessary morbidity for 
56–80% of patients who probably will not harbor nodal 
metastases (17). Moreover, regional recurrence can occur in 
10% of cases even after prophylactic neck dissection, mainly 
in undissected nodal levels, since selective neck dissection 
of levels I-III is usually performed (13,17). Therefore, a 
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strategy of active surveillance by ultrasonography and/
or computed tomography (CT) followed by therapeutic 
neck dissection in case of clinically-positive nodes has 
been proposed as an alternative to upfront elective neck 
dissection. The literature on this topic is frequently based 
on retrospective and small series, while the number of 
prospective trials is limited and often present critical issues 
or methodological biases (3,17,25). Nevertheless, recent 
prospective trials and meta-analyses show that prophylactic 
neck dissection still significantly reduces regional recurrence 
and improves DSS in Stage I-II tongue SCC (3,13). While 
the benefit is evident in patients undergoing follow-up 
without routine CT examination, it is substantially lacking 
in case of close follow-up with imaging (17). Therefore, 
prophylactic selective neck dissection remains the preferred 
treatment policy when managing a cN0 neck in tumors at 
high-risk of occult nodal metastasis. Nevertheless, clinical 
decisions should be always taken based on the evaluation of 
risks and benefits, as a watchful surveillance strategy can be 
beneficial, especially in the elderly and fragile patients.
Conclusions
The 8th Edition of the AJCC/UICC TNM staging system 
performs better than the previous one when applied to 
tongue SCC, showing overall improved prognostication 
for each stage. However, while the difference between 
early- and advanced-staged diseases is solid, the distinction 
between the T1 and T2 categories remains unsatisfactory. 
One reason might be that in early-stage tongue SCC 
more ancillary clinical and histopathologic factors, in 
addition to size and DOI of the primary tumor, have an 
influence on prognosis, while the impact of DOI on DSS 
is strong enough to separate early from advanced tongue 
SCC. Prognostication based on pathologic staging (using 
predictive models like nomograms) is definitively much 
more informative, even though not applicable in the 
preoperative setting and more complex than every TNM 
staging system. However, the probability of nodal metastasis 
in a clinically negative neck is definitely influenced by DOI, 
even though there is uncertainty regarding the magnitude 
of the phenomenon itself. Conversely, the employment 
of TNM staging for choosing treatment, or whether to 
proceed to neck dissection, should be discouraged, as 
staging per se does not adequately separate T1 and T2N0 
patients according to the risk of occult nodal metastasis. 
Further high-quality prospective randomized trials are 
needed to obtain information useful in treatment planning 
of these clinical scenarios.
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